Background
Medtronic Ireland Manufacturing Unlimited Co. owned patents for renal neuromodulation systems and licensed certain rights to Medtronic Vascular Galway Unlimited Company under an exclusive license agreement. Medtronic Ireland retained the right to sue third parties for infringement if the licensee declined to act, the right to veto sublicenses, and royalty interests. Recor Medical, Inc. sued to declare the patents invalid, prompting Medtronic Ireland to assert counterclaims for infringement. The district court dismissed these counterclaims, ruling that Medtronic Ireland lacked the exclusionary rights necessary for Article III standing.
The court’s reasoning
The court held that Medtronic Ireland retained an exclusionary right sufficient to satisfy the irreducible constitutional minimum of standing. The court found that the patent owner’s right to sue was not illusory because it retained royalty interests and the authority to veto sublicenses that could otherwise nullify its rights. The court distinguished prior precedent where rights were found illusory, noting that Medtronic Ireland’s retained rights ensured it maintained a concrete stake in excluding unauthorized practice of the patents.
What it means going forward
Patent owners who license rights to others while retaining a secondary right to sue, veto authority over sublicenses, and royalty interests will likely maintain constitutional standing to enforce their patents in federal court.
Podcast (federal-narrative-summaries): Play in new window | Download